Savara Pharmaceuticals
SVRA
$3.87
Share price
-5.15%
Change (1 day)
26.06%
Change (1 year)
Categories
Savara Pharmaceuticals (SVRA) - P/B ratio
P/B ratio as of June 2024 : 4.39
According to Savara Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 4.39.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Savara Pharmaceuticals - P/B ratio (from 2002 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 4.53 | 176.29% |
| 2022-12-31 | 1.64 | 67.85% |
| 2021-12-31 | 0.9772 | 1.04% |
| 2020-12-31 | 0.9671 | -56.78% |
| 2019-12-31 | 2.24 | -8.99% |
| 2018-12-31 | 2.46 | -35.2% |
| 2017-12-31 | 3.79 | -758.18% |
| 2016-12-31 | -0.5764 | -120.02% |
| 2015-12-31 | 2.88 | 89.09% |
| 2014-12-31 | 1.52 | 53.24% |
| 2013-12-31 | 0.9934 | 57.43% |
| 2012-12-31 | 0.6310 | 129.45% |
| 2011-12-31 | 0.2750 | -81.84% |
| 2010-12-31 | 1.51 | -85.93% |
| 2009-12-31 | 10.8 | 853.32% |
| 2008-12-31 | 1.13 | -13.72% |
| 2007-12-31 | 1.31 | -71.7% |
| 2006-12-31 | 4.62 | -116.44% |
| 2005-12-31 | -28.1 | -678.34% |
| 2004-12-31 | 4.86 | -45.16% |
| 2003-12-31 | 8.87 | -210.83% |
| 2002-12-31 | -8.00 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6954 | -84.15% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 3.48 | -20.81% | 🇺🇸 USA |